Picture of Bicycle Therapeutics logo

BCYC Bicycle Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Bicycle Therapeutics slides on $125 mln share offering

** Drug developer's shares  BCYC.O  drop as much as 3% to
$52
    ** Co commences offering of American Depositary Shares (ADS)
worth $125 mln  urn:newsml:reuters.com:*:nBwb0f4p2a
    ** Each ADS represents one ordinary share, co says
    ** BCYC plans to use proceeds from offering to fund future
products and research and development
    ** Goldman Sachs & Co, Morgan Stanley and SVB Leerink are
the underwriters

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))

Recent news on Bicycle Therapeutics

See all news